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Abstract
Light-induced rhodopsin signaling is turned off with sub-second kinetics by rhodopsin phosphorylation followed by
arrestin-1 binding. To test the availability of the arrestin-1 pool in dark-adapted outer segment (OS) for rhodopsin shutoff,
we measured photoresponse recovery rates of mice with arrestin-1 content in the OS of 2.5%, 5%, 60%, and 100% of wild
type (WT) level by two-flash ERG with the first (desensitizing) flash at 160, 400, 1000, and 2500 photons/rod. The time of half
recovery (thalf) in WT retinas increases with the intensity of the initial flash, becoming ,2.5-fold longer upon activation of
2500 than after 160 rhodopsins/rod. Mice with 60% and even 5% of WT arrestin-1 level recovered at WT rates. In contrast,
the mice with 2.5% of WT arrestin-1 had a dramatically slower recovery than the other three lines, with the thalf increasing
,28 fold between 160 and 2500 rhodopsins/rod. Even after the dimmest flash, the rate of recovery of rods with 2.5% of
normal arrestin-1 was two times slower than in other lines, indicating that arrestin-1 level in the OS between 100% and 5%
of WT is sufficient for rapid recovery, whereas with lower arrestin-1 the rate of recovery dramatically decreases with
increased light intensity. Thus, the OS has two distinct pools of arrestin-1: cytoplasmic and a separate pool comprising
,2.5% that is not immediately available for rhodopsin quenching. The observed delay suggests that this pool is localized at
the periphery, so that its diffusion across the OS rate-limits the recovery. The line with very low arrestin-1 expression is the
first where rhodopsin inactivation was made rate-limiting by arrestin manipulation.
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Introduction
Humans express ,800 different G-protein-coupled receptors
(GPCR), among which rhodopsin is the best characterized [1].
The biochemical mechanism of rod phototransduction serves as a
model of GPCR-driven signaling cascades [1]. Rhodopsin is
activated by photoconversion of covalently attached retinal. Light-
activated rhodopsin catalyzes nucleotide exchange of cognate G
protein transducin, which then activates cGMP phosphodiesterase.
Rhodopsin is inactivated by GRK1 phosphorylation, followed by
high-affinity binding of arrestin-1 when three attached phosphates
are accumulated [2,3]. Comprehensive understanding of systems
behavior of rod photoreceptors requires the knowledge of exact
concentration, localization, and activity of every signaling protein
in the cell. While the functional role of many players in rod
phototransduction have been qualitatively established using
genetically modified mice (reviewed in [4]), the biological
significance of the exact expression level of each protein was
rarely addressed experimentally. The studies where rods with
different expression levels of rhodopsin [5,6], RGS9 [7,8], GRK1
[9], and arrestin [8–10] were functionally characterized yielded
important, often surprising, results. Mouse rods express arrestin-1
and rhodopsin at ,0.8:1 ratio, which makes arrestin-1 the second
most abundant protein in the rod photoreceptor [10–12]. Using
transgenic mice expressing arrestin-1 at levels ranging from 4 to
220% of WT, we recently found that supra-physiological arrestin-
1 levels marginally improve the functional performance of rods
[10]. In addition, rod photoreceptors with arrestin-1 levels below
WT perform as well as other genotypes at dim light, but show
dramatic functional impairment when tested at brighter illumina-
tion. [10]. Importantly, the reduction of arrestin-1 level in the OS
to ,2.5% of WT dramatically slowed the recovery kinetics, as
compared to mice with only twice as much arrestin-1 in the OS
[10]. Here we show that, while the recovery rates in all lines slow
with the increased intensity of the desensitizing flash, the same
‘‘threshold’’ between 5% and 2.5% of arrestin-1 level in the OS is
observed at all flash intensities tested. Remarkably, this threshold is
maintained even at the dimmest desensitizing flash. These data
indicate that ,2.5% of arrestin-1 content in the OS is not
immediately available for rhodopsin quenching, suggesting that
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22797this separate pool of arrestin-1 resides relatively far from
rhodopsin-containing discs. Slow diffusion of arrestin-1 across
the OS in the lowest expressing line apparently delays the recovery
by making rhodopsin inactivation rate-limiting, in contrast to WT
and arrestin-1 hemizygous (Arr1+/2) animals where transducin
inactivation is the slowest process that determines the speed of
recovery [7,8,13]. Please note that we use systematic names of
arrestin proteins: arrestin-1 (historic names S-antigen, 48 kDa
protein, visual or rod arrestin), arrestin-2 (b-arrestin or b-
arrestin1), arrestin-3 (b-arrestin2 or hTHY-ARRX), and ar-
restin-4 (cone or X-arrestin; for unclear reasons its gene is called
‘‘arrestin 3’’ in HUGO database).
Results
Arrestin-1 binding after GRK1 phosphorylation of rhodopsin
[14,15] is the key process in rapid photoresponse recovery in rods
[16] and cones [17]. Arrestin-1 acts by sterically shielding
rhodopsin, precluding further transducsin activation [18,19]. In
the dark, arrestin1 translocates out of OS and localizes primarily
to cell bodies of rod photoreceptors, so the OS contains only a
small proportion of arrestin-1 [10–12,20–22]. Dark-adapted rod
OS of transgenic mice expressing arrestin-1 at 4% (Tr-4
Arr2/2),
12% (Tr-12
Arr2/2), 50% (Arr+/2), and 100% of WT contain
,7.6, 15, 180, and 300 mM arrestin-1, respectively (these
calculations are based on 3 mM rhodopsin concentration in the
OS [10,23]), which constitutes 2.5%, 5%, 60%, and 100% of
normal WT level, respectively. Rod function can be monitored
non-invasively by ERG, where the negative a-wave reflects the
hyperpolarization of the rod cells caused by reduction of
circulating current [24–27]. We used double-flash protocol, where
an initial flash desensitizes rods, and the response to the second
(probe) flash, delivered at varying time intervals after the initial
flash, is measured to determine the extent of recovery. The time of
half-recovery (thalf) is calculated by plotting the amplitude of the
probe flash response as a function of time between flashes [24,28].
Using desensitizing flash of 20.4 logcd*s/m
2 (400 photoisomer-
izations/rod), we previously found that recovery rates of the three
lines with 100%, 60%, and 5% of WT arrestin-1 level in the OS
are surprisingly similar, whereas rod recovery in mice with 2.5% of
normal arrestin-1 content in the OS is dramatically slowed (Fig. 1)
[10]. Considering that the pseudo-first-order rate of arrestin-1
binding to phosphorylated rhodopsin is the product of the on-rate
constant (which was recently measured [29]) multiplied by the
absolute arrestin-1 concentration near rhodopsin-containing discs,
two mechanistic models could account for this ‘‘threshold’’-like
effect. If arrestin-1 is homogeneously distributed throughout OS
cytoplasm, the threshold must depend on the intensity of the
desensitizing flash, so that the activation of more than twice as
many rhodopsins should place Tr-12
Arr2/2 mice with two-fold
greater arrestin-1 content below the threshold. Alternatively,
arrestin-1 distribution in the OS may be non-homogeneous, with
immediately available and relatively unavailable pools. If the latter
pool is roughly equal to arrestin-1 content in the lowest expressing
Figure 1. Reduced arrestin-1 expression slows down photoresponse recovery. The intensities of the first (desensitizing) flashes were 20.8,
20.4, 0, or +0.4 logcd*s/m
2 and second (probe) flash was 0.65 logcd*s/m
2. The a-wave elicited by the probe flash was plotted as a function of time
elapsed after the first flash. Representative recovery curves for indicated genotypes and strengths of desensitizing flash are shown. The interval
between the two flashes was varied from 200 to 120,000 ms. The results for desensitizing flash of 20.4 logcd*s/m
2 were reported previously [10], and
are shown here for comparison. Phi/rod, photoisomerizations/rod. [59]
doi:10.1371/journal.pone.0022797.g001
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Arr2/2 mice would be below the threshold at all
intensities of desensitizing flash, whereas all other lines would
remain above it. To distinguish between these two possibilities, we
used initial desensitizing flashes with intensities that vary ,16-fold,
20.8, 20.4, 0, and +0.4 logcd*s/m
2, corresponding to 160, 400,
1000, and 2500 photoisomerizations/rod (Figs. 1,2; Table 1) [30].
Unexpectedly, we found no significant differences in the thalf of
WT, Arr+/2, and Tr-12
Arr2/2 mice at any intensity of
desensitizing flash tested, despite ,20-fold difference in the
arrestin-1 content in the OS of WT and Tr-12
Arr2/2 animals.
However, the magnitude of the recovery defect in Tr-4
Arr2/2
mice depended on flash intensity. At 160 photoisomerizations/
rod, thalf of Tr-4
Arr2/2 mice was only ,1.8-fold longer than in
other genotypes, but the difference increased to ,5.5-, 12-, and
23-fold at 400, 1000, and 2500 photoisomerizations/rod,
respectively (Fig. 2; Table 1).
Importantly, WT, Arr+/2, and Tr-12
Arr2/2 mice demonstrat-
ed a gradual slowing of the recovery with increasing intensity of
Figure 2. Animals with very low arrestin-1 in the OS show very long time of half recovery. To calculate the time of half recovery, recovery
kinetics were fitted by polynomial nonlinear regression, with R
2.0.95, as described in methods. Means +/2 SD for four animals per genotype are
shown. The data were analyzed by one-way ANOVA with Genotype as main factor followed by Bonferroni post hoc comparison of means. * - p,0.05;
** - p,.001, *** - p,0.001 to WT; + -p ,0.05, ++ -p ,0.001, +++ -p ,0.001 to Arr+/2,a–p ,0.005, b – p,0.01, c – p,0.001 to Tr-12
Arr2/2. Phi/rod,
photoisomerizations/rod.
doi:10.1371/journal.pone.0022797.g002
Table 1. The rates of photoresponse recovery in mice with different arrestin-1 expression.
Genotype 158 phi/rod 398 phi/rod 1000 phi/rod 2512 phi/rod
Arrestin-1
concentration (OS)
Wild type 258645 ms 376647 ms 405658 ms 646656 ms 300 mM
Arr1
+/2 262635 ms 426626 ms 486682 ms 626679 ms 180 mM
Tr-12
Arr12/2 278646 ms 433645 ms 460675 ms 718627 ms 15 mM
Tr-4
Arr12/2 5146183 ms 236861515 ms 55156999 ms 1413763595 ms 7.6 mM
doi:10.1371/journal.pone.0022797.t001
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these three genotypes, as evidenced by lack of interaction between
Genotype and Light factors in two-way-ANOVA (F(6,41)-1.12,
p=0.37 n.s.). In these genotypes thalf increased ,2.5-fold with
desensitizing flash inducing 2,500 instead of 160 photoisomeriza-
tions/rod (Table 1). In sharp contrast, the increase in recovery time
from the dimmest to brightest desensitizing flash for Tr-4
Arr2/2
mice was ,28 fold (Table 1). Virtually identical slowing of the
recovery in WT, Arr+/2, and Tr-12
Arr2/2 animals likely reflects
the increased time that it takes guanylyl cyclase to replenish
hydrolyzed cGMP necessary to open cGMP-gated channels and
restore circulating current, whereas much more dramatic increase
of thalf in Tr-4
Arr2/2 animals must reflect additional processes that
do not operate in the other three genotypes.
Discussion
Rod phototransduction is the only GPCR-driven signaling
cascade where the expression levels of all players are known with
sufficient accuracy to model systems behavior of the cell [13,31–
33] Here we report an unexpected finding that 20-fold reduction
of arrestin-1 content in the dark-adapted rod OS from 100% to
5% of WT level has no appreciable effect on photoresponse
recovery, whereas further 2-fold reduction to 2.5% dramatically
slows this process (Figs. 1,2; Table 1). This remarkable difference
in recovery kinetics is unlikely to be simply the result of depletion
of arrestin-1 in the OS. There are ,70 million rhodopsin
molecules in the mouse OS [30], clustered on approximately 800
discs. This corresponds to ,88,000 rhodopsins per disc. The
calculated amount of arrestin-1 present in the OS for Tr-4
Arr2/2
mice is approximately 7.6 mM, which corresponds to about
200,000 molecules per OS [10]. In the case of even arrestin-1
distribution in the OS, there would be ,250 arrestin-1 molecules
per disc available to quench rhodopsin. However, even at the
dimmest desensitizing flash used, which generates only 160 Rh*/
rod (0.2 Rh*/disc), we observed a 1.8-fold slowing of the recovery,
which increases to .20-fold at ,3 Rh*/disc (Table 1). Arrestin-1
concentration in the WT mouse OS is ,300 mM [10]. Taking into
account known constants of mouse arrestin-1 self-association [34],
this yields ,50 mM active monomer. This results in estimated
pseudo-first-order on-rate of 50 s
21, enabling arrestin-1 to ‘‘check’’
the state of each rhodopsin molecule every 20 msec. This is
consistent with recent estimates of an active rhodopsin lifetime of
,60 ms [7], or possibly even ,30 ms [8,13]. Calculations show
that despite the dramatically reduced arrestin-1 concentration in
Tr-4
Arr2/2 mice, at 7.6 mM there is still enough arrestin-1
monomers in the OS to encounter each rhodopsin every 200 ms.
This difference is sufficient to account for ,200 ms delay, but
cannot explain the multi-second times of half-recovery observed
(Fig. 2; Table 1). Thus, our data suggest that most of arrestin-1 in
the OS of Tr-4
Arr2/2 animals is not immediately available for
rhodopsin quenching.
Self-association could potentially limit arrestin-1 availability.
Arrestin-1 forms dimers and tetramers at physiological concen-
trations [35–37], yet only the monomer is capable of binding
rhodopsin [37,38], because the well-defined rhodopsin-binding
surface of each molecule [39–47] is occluded by other subunits in
the solution tetramer and both possible dimers [38]. Recent
measurements of self-association constants of mouse arrestin-1
yielded Kd dimer =57.5 mM and Kd tetramer =63.1 mM [34].
These values allow the calculation of the half-life of the dimer and
tetramer [48], both of which turn out to be on the order of 12 ms.
Thus, arrestin-1 self-association also cannot account for the multi-
second times of half-recovery in Tr-4
Arr2/2 mice (Table 1).
Sub-cellular distribution of arrestin-1 in rods is strictly light
dependent. In the dark, arrestin-1 is predominantly located in the
inner segment, perinuclear layer, and synaptic terminals, with
relatively small fraction, estimated at 2–4% [12,49], 9% [11], or
,15% [10], residing in the OS. Prolonged bright illumination
triggers the translocation of the majority of arrestin-1 to the OS
[20,49,50]. Different lines of evidence suggest that arrestin-1
movement is either energy-independent, driven by diffusion [49],
may involve active transport [51], or possibly diffusion with active
gating in the cilium [11]. Considering that in the light and dark
arrestin-1 in the rod is at disequilibrium [52], it is clear that,
regardless of the mode of transportation, its distribution must be
determined by the interactions with non-mobile partners:
otherwise the diffusion would quickly ruin concentration gradients
created by any mechanism [53]. Arrestin-1 binds rhodopsin at 1:1
ratio [54,55], and the molar amount of arrestin-1 that can
translocate to the OS in the light is limited by the amount of
rhodopsin present in this compartment [12], indicating that
rhodopsin is the immobile binding partner that holds arrestin-1 in
the OS in the light. Arrestin-1 binds several proteins present in the
cell body, including polymerized tubulin (microtubules) [56,57], c-
Jun N-terminal kinase [58], ubiquitin ligases Mdm2 [58] and
parkin [59], calmodulin [60], N-ethylmaleimide-sensitive factor
[61], and enolase1 [62]. Among these, however, tubulin appears to
be the only sufficiently abundant protein to serve as an ‘‘anchor’’
for arrestin-1 expressed at 0.8:1 ratio to rhodopsin [10-12]. High
concentration of arrestin-1 in the compartments particularly rich
in microtubules (the inner segment, perinuclear area, and synaptic
terminals [63]) in the dark supports this notion. Arrestin-1
translocation is a relatively slow process that takes many minutes
[11,49,50]. Thus, in dark-adapted animals used in this study
arrestin-1 already present in the OS must be responsible for signal
shutoff. Microtubules are not abundant in the OS, but several
bundles near the outer membrane extend along the full length of
the OS and the axoneme [21,63]. Interestingly, arrestin-1
association with microtubules in the OS was previously reported
[64,65]. The diameter of mouse rod OS is ,1.4 mm [31], so that
arrestin-1 bound to these microtubules would need to diffuse for
up to 0.7 mm before reaching rhodopsin. This would take seconds
[31], which matches the observed delay of photoresponse recovery
in Tr-4
Arr2/2 mice, as compared to the Tr-12
Arr2/2 animals
(Table 1), fairly well. Importantly, the observed delay of several
seconds (Table 1) cannot be explained by arrestin-1 diffusion into
the OS from the inner segment: the time arrestin-1 would require
to diffuse over the ,23 mm length of the rod OS would be
significantly longer. Even if one takes into account that in Tr-
12
Arr2/2 and Tr-4
Arr2/2 mice the OS are shorter (,17 mm and
14 mm in the middle retina, respectively [10]), arrestin-1 diffusion
across this distance would take minutes before it can quench
rhodopsin in the OS. Although the exact amount of polymerized
tubulin in the OS is unknown, if it is present in excess over
arrestin-1 at any concentration that significantly exceeds KD of
arrestin-1 binding [66], the majority of arrestin-1 would be
recruited to microtubules. Thus, the simplest model that accounts
for our data is that there are two distinct pools of arrestin-1 in the
OS. At least 2.5% is bound to the microtubules at the plasma
membrane, whereas the rest is distributed throughout OS
cytoplasm, with only the latter being available to quench
rhodopsin signaling on the millisecond timescale. In Tr-4
Arr2/2
animals microtubules take up most of the arrestin-1 present,
leaving relatively little immediately available to rhodopsin. This
slows down shutoff by the time necessary for arrestin-1 diffusion
across the OS. In contrast, in Tr-12
Arr2/2 mice and higher
expressors the microtubules in the OS apparently saturate by the
Two Pools of Arrestin-1 in Rod Outer Segment
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Arr2/2
animals, allowing the rest of arrestin-1 to freely distribute in the
cytoplasm to be immediately available for rhodopsin shutoff.
In summary, our data suggest the existence of two distinct pools
of arrestin-1 in dark-adapted mouse outer segments. To the best of
our knowledge, so far only one genetically modified mouse line
where rhodopsin shutoff was made rate-limiting was described:
mice with low expression of GRK1/2 chimera [67]. In Tr-4
Arr2/2
mice we made rhodopsin shutoff the rate-limiting stage of
photoresponse recovery by low expression of arrestin-1. Collec-
tively, these results strongly support the idea that both phosphor-
ylation and arrestin binding are necessary steps in rhodopsin
shutoff.
Materials and Methods
Ethics Statement
Animal research was conducted in compliance with the NIH
Guide for the Care and Use of Laboratory Animals and approved
by the Vanderbilt University Institutional Animal Care and Use
Committee/Office of Animal Welfare Assurance (protocol ID M/
06/091).
Generation of transgenic mice expressing arrestin-1 at
different levels
The generation of transgenic animals expressing arrestin-1 at
various levels under the pRho4-1 rhodopsin promoter has been
described previously [10,12,49], and the arrestin-1 content in the
dark-adapted OS of these mice was quantified by Western blot
[10].
Electroretinography (ERG)
Electroretinograms were recorded from 6 to 8 week old mice
reared in 12/12 light-dark cycle (90610 lux in the cage during
light period). Animals were dark-adapted overnight, as described
[10,68]. Mice were anesthetized under dim red light by ip
injection of (in mg/g body weight) 15–20 ketamine, 6–8 xylazine,
600–800 urethane in PBS. The pupils were dilated with 1%
tropicamide in PBS before and throughout the experiment. An eye
electrode made with a coiled 0.2 mm platinum wire was placed on
the cornea, a tungsten needle reference electrode was placed in the
cheek, and ground needle electrode in the tail [24,30,69]. ERG
data was collected using the electrophysiologic system UTAS E-
3000 (LKC Technologies, Inc.) connected to a Ganzfeld chamber
that produced brief (from 20 ms to 1 ms) full field flash stimuli. The
various light intensities used were calibrated by the manufacturer
and computer controlled. Because mice are sensitive to temper-
ature, animals were placed on a heating pad connected to a
temperature control unit to maintain the temperature at 37–38uC
throughout the experiment to reduce variability.
The double flash recording was used to analyze the kinetics of
recovery [24,25,28,70,71]. A test flash was delivered to suppress
the circulating current of the rod photoreceptors. The recovery
was monitored by delivering a second (probe) flash after various
time intervals between the two flashes, that ranged from 200 to
120,000 ms. The intensity of the test flash was either 20.8, 20.4,
0, or +0.4 logcd*s/m
2, corresponding to ,160, ,400, ,1000, and
,2500 photoisomerizations per rod [30]. The following probe
flash was 0.65 logcd*s/m
2, corresponding to ,4,500 isomeriza-
tions per rod [30]. Sufficient time for dark adaptation was allowed
between trials, as determined by the reproducibility of the
response to the test flash. Time-to-peak (implicit time) of the a-
wave at the intensity of the probe flash was not significantly
different in all four genotypes. This finding along with the shape of
the a-wave indicates that the intrusion of b-wave and oscillation
potentials [25,28] did not differentially affect different genotypes.
The normalized amplitude of the probe flash a-wave was plotted
as a function of time between the two flashes. Instead of fitting the
data points to a theoretical equation, which is inevitably based on
certain assumptions that may not be correct for all of the
genotypes used, we fitted curves with polynomial nonlinear
regression using GraphPad Prism (Version 4.0) and considered
R
2.0.95 as a criterion for a good fit. The rate of recovery was
characterized by the time interval necessary for half recovery (thalf),
as described [10,24,28,68].
Statistical Analysis
The data were analyzed by for each light level separately by
one-way ANOVA with Genotype as main factor. To examine the
change in recovery time with light intensity, the data for each
genotype were analyzed separately with Light as main factor.
Means were compared using Bonferroni post hoc test with
correction for multiple comparisons. In all cases, p,0.05 was
considered significant.
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